The University of Chicago Comer Children's Hospital formerly University of Chicago Children's Hospital is a nationally ranked, freestanding, 172-bed, pediatric acute care children's hospital adjacent to University of Chicago Medical Center.

There are 172 beds in University of Chicago Comer Children's Hospital.

During the past decade, University of Chicago Comer Children's Hospital conducted 30 clinical trials. In the 10-year time frame, 30 clinical trials started and 13 clinical trials were completed, i.e. on average, 43.3% percent of trials that started reached the finish line to date. In the past 5 years, 11 clinical trials started and 7 clinical trials were completed. i.e. 63.6% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Chicago Comer Children's Hospital" #1 sponsor was "National Institute of Allergy and Infectious Diseases (NIAID)" with 22 trials, followed by "New Approaches to Neuroblastoma Therapy Consortium" with 13 trials sponsored, "Aimmune Therapeutics, Inc." with 5 trials sponsored, "University of Chicago" with 5 trials sponsored and "Children's Hospital Los Angeles" with 5 trials sponsored. Other sponsors include 31 different institutions and companies that sponsored additional 35 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Chicago Comer Children's Hospital" #1 collaborator was "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 11 trials as a collaborator, "National Cancer Institute (NCI)" with 10 trials as a collaborator, "Glaxo Wellcome" with 5 trials as a collaborator, "Pfizer" with 3 trials as a collaborator and "University of Chicago" with 3 trials as a collaborator. Other collaborators include 51 different institutions and companies that were collaborators in the rest 53 trials.

According to Clinical.Site data, the most researched conditions in "University of Chicago Comer Children's Hospital" are "HIV Infections" (22 trials), "Neuroblastoma" (19 trials), "Peanut Allergy" (6 trials), "Pregnancy" (5 trials) and "HIV Seronegativity" (2 trials). Many other conditions were trialed in "University of Chicago Comer Children's Hospital" in a lesser frequency.

Most popular intervention types in "University of Chicago Comer Children's Hospital" are "Drug" (60 trials), "Other" (10 trials), "Biological" (9 trials), "Radiation" (6 trials) and "Procedure" (4 trials). Other intervention types were less common.

The name of intervention was led by "Zidovudine" (9 trials), "Placebo" (8 trials), "Nevirapine" (7 trials), "Didanosine" (5 trials) and "AR101" (4 trials). Other intervention names were less common.

The vast majority of trials in "University of Chicago Comer Children's Hospital" are 82 trials for "All" genders and 3 trials for "Female" genders.

Currently, there are NaN active trials in "University of Chicago Comer Children's Hospital". undefined are not yet recruiting, 12 are recruiting, 7 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 55 completed trials in University of Chicago Comer Children's Hospital, undefined suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in University of Chicago Comer Children's Hospital, 25 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 23 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 10 trials that are defined as “Not Applicable".